Author:
de Diego-Otero Yolanda,Romero-Zerbo Yanina,Bekay Rajaa el,Decara Juan,Sanchez Lourdes,Fonseca Fernando Rodriguez-de,Arco-Herrera Ignacio del
Publisher
Springer Science and Business Media LLC
Subject
Psychiatry and Mental health,Pharmacology
Reference65 articles.
1. Ainsah O, Nabishah BM, Osman CB, Khalid BA (1999). Naloxone and vitamin E block stress-induced reduction of locomotor activity and elevation of plasma corticosterone. Exp Clin Endocrinol Diabetes 107: 462–467.
2. Bakker CE, Verheij C, Willemsen R, Van Der Helm R, Oerlemans F, Vermey M et al (1994). Fmr1 knockout mice: a model to study fragile X mental retardation. Cell 78: 23–33.
3. Bardoni B, Davidovic L, Bensaid M, Khandjian EW (2006). The fragile X syndrome: exploring its molecular basis and seeking a treatment. Expert Rev Mol Med 8: 1–16.
4. Bradford MM (1976). A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72: 248–254.
5. Brown V, Jin P, Ceman S, Darnell JC, O’Donnell WT, Tenenbaum SA et al (2001). Microarray identification of FMRP-associated brain mRNAs and altered mRNA translational profiles in fragile X syndrome. Cell 107: 477–487.
Cited by
98 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献